Is GoodRx Stock a Buy?
GoodRx Holdings (NASDAQ: GDRX) was one of the top healthcare IPOs of 2020, and today it has a market cap of $17 billion. However, it's been on a bumpy ride since the stock made its debut in September -- falling by more than 13%, even as the S&P 500 climbed by 16%. Although there are many growth opportunities for the company, it's also facing some risks, especially with Amazon (NASDAQ: AMZN) recently launching its pharmacy business and showing a greater interest in healthcare.
For investors, it can be challenging to determine if the risks outweigh the potential rewards, and whether GoodRx is a good buy. I'll try to answer that question by looking at the company's overall business and how well it's been doing, its current valuation, and just how much of a threat Amazon poses.
Image source: Getty Images.
Source Fool.com
